Hedge Fund - Prosight Capital
Bridgebio Pharma Inc. (BBIO)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $2,294,700 | 0.47% | 30,000 | $65.64 |
| 2 | 2025 - Q3 (2025-09-30) | $13,738,130 | 3.2% | 264,500 | $48.77 |
| 3 | 2025 - Q2 (2025-06-30) | $20,410,625 | 4.98% | 472,687 | $36.37 |
| 4 | 2025 - Q1 (2025-03-31) | $21,087,700 | 6.93% | 610,000 | $33.72 |
| 5 | 2024 - Q4 (2024-12-31) | $27,302,800 | 7.54% | 995,000 | $25.84 |
| 6 | 2024 - Q3 (2024-09-30) | $27,670,183 | 6.8% | 1,086,810 | $26.25 |
| 7 | 2024 - Q2 (2024-06-30) | $20,264,000 | 6.05% | 800,000 | $27.34 |
| 8 | 2024 - Q1 (2024-03-31) | $18,228,268 | 5.07% | 589,530 | $34.01 |
| 9 | 2023 - Q2 (2023-06-30) | $0 | 0% | 0 | $15.05 |
| 10 | 2023 - Q1 (2023-03-31) | $215,540 | 0.1% | 13,000 | $11.66 |
| 11 | 2022 - Q4 (2022-12-31) | $678,386 | 0.36% | 89,027 | $9.57 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center